FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy

Adjuvant Treatment in Premenopausal Breast Cancer

NCT06807749 ·Status: NOT_YET_RECRUITING

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

NCT06762977 ·Status: RECRUITING

Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer

NCT01926964 ·Status: COMPLETED

Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 ·Status: COMPLETED

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer

NCT04775043 ·Status: COMPLETED

Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer

NCT06738459 ·Status: RECRUITING

Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation

NCT05772390 ·Status: RECRUITING ·Phase: PHASE2

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 ·Status: RECRUITING

Immunomonitoring of Breast Cancer Patients During Systemic Treatment

NCT04925856 ·Status: RECRUITING ·Phase: NA

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS

NCT02766881 ·Status: COMPLETED

Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer

NCT04781062 ·Status: UNKNOWN ·Phase: NA

Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer

NCT01837563 ·Status: TERMINATED

"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"

NCT06871501 ·Status: NOT_YET_RECRUITING

Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET

NCT02850302 ·Status: COMPLETED ·Phase: NA

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

NCT03772197 ·Status: COMPLETED

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928 ·Status: RECRUITING ·Phase: NA

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

NCT07093775 ·Status: NOT_YET_RECRUITING

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

NCT06708910 ·Status: RECRUITING

Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer

NCT01804309 ·Status: COMPLETED

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

NCT02347449 ·Status: COMPLETED ·Phase: NA

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

NCT01513408 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)

NCT03252717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.

NCT05699291 ·Status: COMPLETED

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

NCT01569321 ·Status: TERMINATED ·Phase: NA

Breast Cancer During Pregnancy

NCT02102282 ·Status: UNKNOWN